<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="32">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on August 12, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04528641</url>
  </required_header>
  <id_info>
    <org_study_id>RT-CoV-2</org_study_id>
    <nct_id>NCT04528641</nct_id>
  </id_info>
  <brief_title>Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine</brief_title>
  <official_title>A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReiThera Srl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ReiThera Srl</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RT-CoV-2 is a Phase I, open-label, dose escalation multicenter clinical trial to assess&#xD;
      safety and immunogenicity of the candidate Coronavirus disease (COVID-19) vaccine GRAd-COV2&#xD;
      in Italian healthy volunteers aged 18-55 years and 65-85 years inclusive. GRAd-COV2 is based&#xD;
      on a novel replication defective Gorilla Adenovirus and encodes for SARS-COV-2 Spike protein.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RT-CoV-2 is a Phase I, open-label, dose escalation multicenter clinical trial to assess&#xD;
      safety and immunogenicity of the candidate Coronavirus disease (COVID-19) vaccine GRAd-COV2&#xD;
      in Italian healthy volunteers aged 18-55 years and 65-85 years inclusive. GRAd-COV2 is based&#xD;
      on a novel replication defective Gorilla Adenovirus and encodes for SARS-COV-2 full length&#xD;
      prefusion stabilized Spike protein. GRAd-COV2 is developed and manufactured by ReiThera Srl.&#xD;
&#xD;
      This study will evaluate a singular intramuscular administration of GRAd-COV2 at 3 dose&#xD;
      levels: 5e10, 1e11, 2e11viral particles (vp). There will be 6 study arms for a total of 90&#xD;
      healthy volunteers, divided into 2 cohorts of age, 18-55y and 65-85y, respectively.&#xD;
&#xD;
      Participants will be followed up for 24 weeks after vaccination. Follow up includes safety&#xD;
      and immunogenicity assessment. Follow up visits will occur at day2, then 1, 2, 4, 8, 12, 24&#xD;
      weeks after vaccination.&#xD;
&#xD;
      The primary objective is to evaluate the safety and reactogenicity of a single dose&#xD;
      vaccination schedule of GRAd-COV2 across 3 dosages in healthy younger and older adults. The&#xD;
      secondary objective is to evaluate humoral and cellular immunogenicity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2020</start_date>
  <completion_date type="Actual">May 19, 2021</completion_date>
  <primary_completion_date type="Actual">May 19, 2021</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Phase I, open-label, dose escalation, clinical trial to assess the safety and immunogenicity of the candidate GRAd-COV2 vaccine in 90 healthy volunteers aged 18-55 years and elderly volunteers aged 65-85 years. The vaccine will be administered intramuscularly once in time.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Solicited Local AE Signs and Symptoms 7 Days Following the Vaccination</measure>
    <time_frame>7 days following the vaccination</time_frame>
    <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited local AE signs and symptoms were collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Solicited Systemic AE Signs and Symptoms 7 Days Following the Vaccination</measure>
    <time_frame>7 days following the vaccination</time_frame>
    <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited systemic AE signs and symptoms were collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Unsolicited AE 28 Days Following the Vaccination</measure>
    <time_frame>28 days following the vaccination</time_frame>
    <description>Occurrence of unsolicited AEs: unsolicited AEs were collected using the patient Diary and reported as &quot;Any AE&quot; occurring 28 days following the vaccination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Serious AE 24 Weeks Following the Vaccination</measure>
    <time_frame>24 weeks following the vaccination</time_frame>
    <description>Occurrence of any treatment - emergent serious AE and treatment - emergent SAE related to study drug was monitored during the study period (24 weeks following vaccination)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Leucocytes From Baseline</measure>
    <time_frame>baseline, Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Basophils From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Eosinophils From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Neutrophils From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
    <description>Change from baseline was calculated as the value at each week minus the value at the baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Monocytes From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Lymphocytes From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Erythrocytes From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hematocrit From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Platelets From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hemoglobin From Baseline</measure>
    <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sodium From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Potassium From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Alkaline Phosphatase From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Alanine Aminotransferase From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Aspartate Aminotransferase From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Direct Bilirubin Form Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Bilirubin From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Albumin Form Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Creatinine Form Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Lactate Dehydrogenase From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Urea Nitrogen From Baseline</measure>
    <time_frame>week 1,2,4,8,12, and 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Positive, Negative or Indeterminate Seroconversion for Anti-s Antibody</measure>
    <time_frame>week 1, 2, 4, 8, 12, and 24</time_frame>
    <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
Immunogenicity Result: Seroconversion for Anti-S Antibody&#xD;
Interpretation: n. of subjects positive, negative or indeterminate at week 1, 2, 4, 8, 12, and 24 after vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Positive, Negative Anti-n Antibody</measure>
    <time_frame>week 1, 2, 4, 8, 12 and 24</time_frame>
    <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
cellular and humoral immune parameters evaluated: anti-N Antibody Interpretation: n. of subjects positive, negative at week 1, 2, 4, 8, 12 and 24 compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Positive, Negative for Micro Neutralization Test</measure>
    <time_frame>week 4 and week 24</time_frame>
    <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated: Micro Neutralization test&#xD;
Interpretation: n. of positive and negative subjects at week 4 and week 24 by evaluating geometric mean titer change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunogenicity - T-cell Response</measure>
    <time_frame>baseline, week 2, week 4, week 8, week 12, week 24</time_frame>
    <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated.&#xD;
T-cells were evaluated on frozen and fresh (week2) samples&#xD;
Within-cohort comparisons to assess the difference in immune response according to different doses in the same population Across-the-cohort comparison to assess whether elderlies and adults have a different pattern of immune response after vaccination at different endpoints&#xD;
Unit: spot-forming cells [SFC]/1 × 10^6 peripheral blood mononuclear cell [PBMC]&#xD;
Interpretation: values higher than at baseline are indicative of a persistent spike-specific memory T-cell establishment.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Arm 1 - Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 - Intermediate dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3 - High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4 - Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 5 - Intermediate dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 6 - High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>GRAd-COV2</intervention_name>
    <description>Single intramuscular administration.</description>
    <arm_group_label>Arm 1 - Low dose</arm_group_label>
    <arm_group_label>Arm 2 - Intermediate dose</arm_group_label>
    <arm_group_label>Arm 3 - High dose</arm_group_label>
    <arm_group_label>Arm 4 - Low dose</arm_group_label>
    <arm_group_label>Arm 5 - Intermediate dose</arm_group_label>
    <arm_group_label>Arm 6 - High dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A subject must meet all of the following criteria to be eligible to participate in this&#xD;
        study:&#xD;
&#xD;
          1. Provides written informed consent prior to initiation of any study procedures.&#xD;
&#xD;
          2. Be able to understand and agrees to comply with planned study procedures and be&#xD;
             available for all study visits.&#xD;
&#xD;
          3. Agrees to the collection of venous blood per protocol.&#xD;
&#xD;
          4. Confirms to have not donated blood three months before the study&#xD;
&#xD;
          5. Agrees to refrain from blood during the study and until the three months after the end&#xD;
             of the study.&#xD;
&#xD;
          6. Body Mass Index 18-29 kg/m2, inclusive, at screening.&#xD;
&#xD;
          7. Premenopausal women must agree to use one acceptable primary form of contraception.&#xD;
&#xD;
          8. Premenopausal women must have a negative urine pregnancy test the day of vaccination&#xD;
             and are routinely using - and willing to use up to six months from vaccine&#xD;
             administration - an effective method of birth control resulting in a low failure rate&#xD;
             (i.e., hormonal contraception, condoms in combination with a spermicidal cream, male&#xD;
             partner sterilization-vasectomy or total sexual abstinence).&#xD;
&#xD;
          9. Oral temperature ≤37.0 degrees Celsius the day of the administration of the vaccine&#xD;
&#xD;
         10. Pulse no greater than 100 beats per minute.&#xD;
&#xD;
         11. Systolic blood pressure (BP) is 85 to 139 mmHg, inclusive the day of vaccination.&#xD;
&#xD;
         12. Should not show laboratory values outside the normal range which may have clinical&#xD;
             significance even in absence of specific signs or symptoms.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A subject who meets any of the following criteria will be excluded from participation in&#xD;
        this study:&#xD;
&#xD;
          1. Positive serology for anti-HIV-Ab&#xD;
&#xD;
          2. Positive HbBsAg&#xD;
&#xD;
          3. Positive anti-HCV-Ab&#xD;
&#xD;
          4. Positive for SARS-CoV-2 (either anti-S-Ab or anti-N-Ab)&#xD;
&#xD;
          5. Acute illness, as determined by the site PI or appropriate sub-investigator, the day&#xD;
             of vaccination.&#xD;
&#xD;
          6. Breastfeeding women&#xD;
&#xD;
          7. Autoimmune and hyper-inflammatory condition&#xD;
&#xD;
          8. History of atopy (or any IgE associated condition) who had required treatment over the&#xD;
             last 6 months;&#xD;
&#xD;
          9. History of hypersensitivity or severe allergic reaction (e.g., anaphylaxis,&#xD;
             generalized urticaria, angioedema, other significant reaction) to any previous&#xD;
             licensed or unlicensed vaccines;&#xD;
&#xD;
         10. Assumption of any immunomodulatory medication over the last 4 months (including, but&#xD;
             not limited to, systemic corticosteroids, allergy injections, immunoglobulin,&#xD;
             interferon, immunomodulators, cytotoxic drugs, or other similar or toxic drugs). The&#xD;
             use of low dose topical, ophthalmic, inhaled, and intranasal steroid preparations will&#xD;
             be permitted.&#xD;
&#xD;
         11. Presence of self-reported or medically documented significant medical condition&#xD;
&#xD;
         12. Presence of self-reported or medically documented significant psychiatric condition&#xD;
&#xD;
         13. Significant cardiovascular disease needing therapy or history of myocarditis or&#xD;
             pericarditis or heart surgery. Patients in treatment with Sartans or ACE-Inhibitors&#xD;
             and good response to therapy may be included.&#xD;
&#xD;
         14. Neurological or neurodevelopmental conditions (e.g., history of migraines in the past&#xD;
             5 years, epilepsy, stroke, seizures in the last 3 years, encephalopathy, focal&#xD;
             neurologic deficits, Guillain-Barré syndrome, encephalomyelitis or transverse&#xD;
             myelitis).&#xD;
&#xD;
         15. Ongoing malignancy or recent diagnosis of malignancy in the last five years excluding&#xD;
             basal cell and squamous cell carcinoma of the skin, which are allowed.&#xD;
&#xD;
         16. Primary or secondary immunodeficiency of any cause.&#xD;
&#xD;
         17. Participated in another investigational study involving vaccination of biologic&#xD;
             compounds in the last 12 months.&#xD;
&#xD;
         18. Currently enrolled in or plans to participate in another clinical trial with an&#xD;
             investigational agent that will be received during the study-reporting period.&#xD;
&#xD;
         19. Administration of immunoglobulins and/or any blood or blood products within the 4&#xD;
             months before the first vaccine administration or at any time during the study.&#xD;
&#xD;
         20. Has any significant disorder of coagulation.&#xD;
&#xD;
         21. Has any chronic liver disease, including fatty liver.&#xD;
&#xD;
         22. Has a history of alcohol abuse or other recreational drug use within 6 months before&#xD;
             the first vaccine administration.&#xD;
&#xD;
         23. Has any abnormality or permanent body art (e.g., tattoo) that would interfere with the&#xD;
             ability to observe local reactions at the injection site (deltoid region).&#xD;
&#xD;
         24. Received or plans to receive additional vaccination within 4 weeks before or after&#xD;
             each vaccination.&#xD;
&#xD;
         25. Has been reported as a case (confirmed or probable) of COVID-19 from the regional&#xD;
             health system&#xD;
&#xD;
         26. Has any clinical conditions that, in the opinion of the site PI or appropriate&#xD;
             sub-investigator, precludes study participation, this includes any acute, subacute,&#xD;
             intermittent or chronic medical disease or condition that would place the subject at&#xD;
             an unacceptable risk of injury, render the subject unable to meet the requirements of&#xD;
             the protocol, or may interfere with the evaluation of responses or the subject's&#xD;
             successful completion of this trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simone Lanini</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Nazionale per le Malattie Infettive &quot;Lazzaro Spallanzani&quot; IRCCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>INMI Spallanzani</name>
      <address>
        <city>Rome</city>
        <zip>00149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Ricerche Cliniche</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2022</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <results_first_submitted>January 17, 2022</results_first_submitted>
  <results_first_submitted_qc>February 7, 2022</results_first_submitted_qc>
  <results_first_posted type="Actual">February 8, 2022</results_first_posted>
  <last_update_submitted>February 7, 2022</last_update_submitted>
  <last_update_submitted_qc>February 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 30, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04528641/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 23, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04528641/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>a total of 180 subjects were screened and 98 subjects were enrolled in the study. seven out of 98 enrolled subjects were not administered vaccine because of withdrawal by subjects (3 subjects) and because the protocol allowed Screening period 21 days passed (4 subjects). a total of 91 subjects were administered vaccine.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1 - Low Dose</title>
          <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 - Intermediate Dose</title>
          <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="P3">
          <title>Arm 3 - High Dose</title>
          <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="P4">
          <title>Arm 4 - Low Dose</title>
          <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="P5">
          <title>Arm 5 - Intermediate Dose</title>
          <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="P6">
          <title>Arm 6 - High Dose</title>
          <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="16"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1 - Low Dose</title>
          <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2 - Intermediate Dose</title>
          <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B3">
          <title>Arm 3 - High Dose</title>
          <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B4">
          <title>Arm 4 - Low Dose</title>
          <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B5">
          <title>Arm 5 - Intermediate Dose</title>
          <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B6">
          <title>Arm 6 - High Dose</title>
          <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="16"/>
            <count group_id="B5" value="15"/>
            <count group_id="B6" value="15"/>
            <count group_id="B7" value="91"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.9" spread="9.1"/>
                    <measurement group_id="B2" value="37.0" spread="10.2"/>
                    <measurement group_id="B3" value="36.2" spread="11.1"/>
                    <measurement group_id="B4" value="69.5" spread="4.6"/>
                    <measurement group_id="B5" value="70.8" spread="5.6"/>
                    <measurement group_id="B6" value="70.0" spread="3.5"/>
                    <measurement group_id="B7" value="53.1" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Demographic - weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.9" spread="12.172"/>
                    <measurement group_id="B2" value="69.7" spread="14.91"/>
                    <measurement group_id="B3" value="70.9" spread="13.49"/>
                    <measurement group_id="B4" value="73.61" spread="12.874"/>
                    <measurement group_id="B5" value="70.37" spread="10.181"/>
                    <measurement group_id="B6" value="70.9" spread="10.54"/>
                    <measurement group_id="B7" value="71.59" spread="12.224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Demographic - Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173.3" spread="9.82"/>
                    <measurement group_id="B2" value="171.9" spread="10.93"/>
                    <measurement group_id="B3" value="173.8" spread="10.21"/>
                    <measurement group_id="B4" value="169.0" spread="9.01"/>
                    <measurement group_id="B5" value="168.1" spread="11.30"/>
                    <measurement group_id="B6" value="169.7" spread="9.47"/>
                    <measurement group_id="B7" value="170.9" spread="10.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Demographic - BMI</title>
          <units>Kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.514" spread="2.5747"/>
                    <measurement group_id="B2" value="23.367" spread="3.0412"/>
                    <measurement group_id="B3" value="23.332" spread="2.7751"/>
                    <measurement group_id="B4" value="24.767" spread="3.0552"/>
                    <measurement group_id="B5" value="24.574" spread="2.5569"/>
                    <measurement group_id="B6" value="25.035" spread="2.2006"/>
                    <measurement group_id="B7" value="24.514" spread="2.5747"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Solicited Local AE Signs and Symptoms 7 Days Following the Vaccination</title>
        <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited local AE signs and symptoms were collected.</description>
        <time_frame>7 days following the vaccination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Solicited Local AE Signs and Symptoms 7 Days Following the Vaccination</title>
          <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited local AE signs and symptoms were collected.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Injection site pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site Haematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Solicited Systemic AE Signs and Symptoms 7 Days Following the Vaccination</title>
        <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited systemic AE signs and symptoms were collected.</description>
        <time_frame>7 days following the vaccination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Solicited Systemic AE Signs and Symptoms 7 Days Following the Vaccination</title>
          <description>Participants were monitored for 7 days post-vaccination and the occurrence of solicited systemic AE signs and symptoms were collected.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pyrexia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutropeonia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Back Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cough</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Faeces Soft</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hot flush</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperkalaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle strain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tooth fracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dyspnoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oropharyngeal pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ecchymosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tooth abscess</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chalazion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphadenopathy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Unsolicited AE 28 Days Following the Vaccination</title>
        <description>Occurrence of unsolicited AEs: unsolicited AEs were collected using the patient Diary and reported as &quot;Any AE&quot; occurring 28 days following the vaccination.</description>
        <time_frame>28 days following the vaccination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=14&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Unsolicited AE 28 Days Following the Vaccination</title>
          <description>Occurrence of unsolicited AEs: unsolicited AEs were collected using the patient Diary and reported as &quot;Any AE&quot; occurring 28 days following the vaccination.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1 - any AE : Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 1 - any AE : Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 1 - any AE : Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2 - any AE: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2 - any AE: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2 - any AE: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 3 - Any AE: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 3 - any AE: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 3 - any AE: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4 - any AE: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4 - any AE: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4 - any AE: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Serious AE 24 Weeks Following the Vaccination</title>
        <description>Occurrence of any treatment - emergent serious AE and treatment - emergent SAE related to study drug was monitored during the study period (24 weeks following vaccination)</description>
        <time_frame>24 weeks following the vaccination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Serious AE 24 Weeks Following the Vaccination</title>
          <description>Occurrence of any treatment - emergent serious AE and treatment - emergent SAE related to study drug was monitored during the study period (24 weeks following vaccination)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any treatment-emergent SAE related to study drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any treatment-emergent SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Leucocytes From Baseline</title>
        <time_frame>baseline, Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Leucocytes From Baseline</title>
          <units>10^9 leucocytes /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.033" spread="1.285"/>
                    <measurement group_id="O2" value="-0.199" spread="1.3799"/>
                    <measurement group_id="O3" value="-0.265" spread="0.5758"/>
                    <measurement group_id="O4" value="-0.159" spread="0.7563"/>
                    <measurement group_id="O5" value="-0.019" spread="0.4475"/>
                    <measurement group_id="O6" value="0.055" spread="0.6884"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.218" spread="1.354"/>
                    <measurement group_id="O2" value="0.091" spread="1.2248"/>
                    <measurement group_id="O3" value="-0.099" spread="0.6808"/>
                    <measurement group_id="O4" value="0.158" spread="0.9098"/>
                    <measurement group_id="O5" value="0.329" spread="0.7771"/>
                    <measurement group_id="O6" value="0.190" spread="0.6531"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.230" spread="1.2881"/>
                    <measurement group_id="O2" value="0.472" spread="1.2324"/>
                    <measurement group_id="O3" value="-0.286" spread="0.6787"/>
                    <measurement group_id="O4" value="-0.261" spread="1.0477"/>
                    <measurement group_id="O5" value="0.186" spread="1.0368"/>
                    <measurement group_id="O6" value="0.186" spread="1.1456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.154" spread="0.8825"/>
                    <measurement group_id="O2" value="0.094" spread="1.2006"/>
                    <measurement group_id="O3" value="-0.029" spread="1.0882"/>
                    <measurement group_id="O4" value="-0.013" spread="0.8416"/>
                    <measurement group_id="O5" value="0.080" spread="0.5862"/>
                    <measurement group_id="O6" value="-0.087" spread="0.6728"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.045" spread="1.0228"/>
                    <measurement group_id="O2" value="0.409" spread="1.7620"/>
                    <measurement group_id="O3" value="0.133" spread="1.1654"/>
                    <measurement group_id="O4" value="-0.060" spread="0.9897"/>
                    <measurement group_id="O5" value="0.357" spread="0.8966"/>
                    <measurement group_id="O6" value="-0.175" spread="0.7302"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.695" spread="1.199"/>
                    <measurement group_id="O2" value="-0.125" spread="1.0887"/>
                    <measurement group_id="O3" value="-0.263" spread="0.8854"/>
                    <measurement group_id="O4" value="-0.310" spread="1.0615"/>
                    <measurement group_id="O5" value="0.196" spread="0.7996"/>
                    <measurement group_id="O6" value="0.199" spread="0.8817"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Basophils From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Basophils From Baseline</title>
          <units>10^9 basophils/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.002" spread="0.0094"/>
                    <measurement group_id="O2" value="-0.002" spread="0.0147"/>
                    <measurement group_id="O3" value="-0.010" spread="0.0169"/>
                    <measurement group_id="O4" value="-0.001" spread="0.0141"/>
                    <measurement group_id="O5" value="-0.009" spread="0.0113"/>
                    <measurement group_id="O6" value="-0.001" spread="0.0162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.001" spread="0.0122"/>
                    <measurement group_id="O2" value="0.007" spread="0.0129"/>
                    <measurement group_id="O3" value="-0.002" spread="0.0142"/>
                    <measurement group_id="O4" value="0.004" spread="0.011"/>
                    <measurement group_id="O5" value="0.003" spread="0.0272"/>
                    <measurement group_id="O6" value="0.004" spread="0.0124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.004" spread="0.0118"/>
                    <measurement group_id="O2" value="0.0" spread="0.0120"/>
                    <measurement group_id="O3" value="-0.003" spread="0.150"/>
                    <measurement group_id="O4" value="0.001" spread="0.054"/>
                    <measurement group_id="O5" value="-0.003" spread="0.0129"/>
                    <measurement group_id="O6" value="0.004" spread="0.0199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.001" spread="0.0122"/>
                    <measurement group_id="O2" value="0.001" spread="0.0133"/>
                    <measurement group_id="O3" value="-0.001" spread="0.0119"/>
                    <measurement group_id="O4" value="-0.002" spread="0.0164"/>
                    <measurement group_id="O5" value="-0.005" spread="0.0092"/>
                    <measurement group_id="O6" value="0.003" spread="0.0116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.002" spread="0.0142"/>
                    <measurement group_id="O2" value="0.003" spread="0.0159"/>
                    <measurement group_id="O3" value="0.0" spread="0.0108"/>
                    <measurement group_id="O4" value="0.0" spread="0.0121"/>
                    <measurement group_id="O5" value="0.0" spread="0.0156"/>
                    <measurement group_id="O6" value="0.002" spread="0.0142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.004" spread="0.0135"/>
                    <measurement group_id="O2" value="0.004" spread="0.0112"/>
                    <measurement group_id="O3" value="-0.001" spread="0.0146"/>
                    <measurement group_id="O4" value="-0.003" spread="0.0168"/>
                    <measurement group_id="O5" value="-0.004" spread="0.0140"/>
                    <measurement group_id="O6" value="-0.001" spread="0.0141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Eosinophils From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Eosinophils From Baseline</title>
          <units>10^9 eosinophils /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.009" spread="0.0478"/>
                    <measurement group_id="O2" value="-0.017" spread="0.0649"/>
                    <measurement group_id="O3" value="-0.007" spread="0.0555"/>
                    <measurement group_id="O4" value="0.031" spread="0.0483"/>
                    <measurement group_id="O5" value="0.009" spread="0.0674"/>
                    <measurement group_id="O6" value="0.006" spread="0.0467"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.014" spread="0.0370"/>
                    <measurement group_id="O2" value="0.029" spread="0.0644"/>
                    <measurement group_id="O3" value="0.024" spread="0.0697"/>
                    <measurement group_id="O4" value="0.046" spread="0.0574"/>
                    <measurement group_id="O5" value="0.037" spread="0.0743"/>
                    <measurement group_id="O6" value="0.021" spread="0.0439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.013" spread="0.0873"/>
                    <measurement group_id="O2" value="-0.003" spread="0.0603"/>
                    <measurement group_id="O3" value="-0.003" spread="0.0471"/>
                    <measurement group_id="O4" value="-0.008" spread="0.0680"/>
                    <measurement group_id="O5" value="0.001" spread="0.0442"/>
                    <measurement group_id="O6" value="0.027" spread="0.0870"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.023" spread="0.0716"/>
                    <measurement group_id="O2" value="-0.002" spread="0.1202"/>
                    <measurement group_id="O3" value="-0.033" spread="0.0979"/>
                    <measurement group_id="O4" value="0.010" spread="0.0732"/>
                    <measurement group_id="O5" value="0.006" spread="0.0617"/>
                    <measurement group_id="O6" value="0.021" spread="0.0935"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.004" spread="0.0840"/>
                    <measurement group_id="O2" value="-0.017" spread="0.077"/>
                    <measurement group_id="O3" value="-0.013" spread="0.1085"/>
                    <measurement group_id="O4" value="-0.001" spread="0.0804"/>
                    <measurement group_id="O5" value="0.007" spread="0.0707"/>
                    <measurement group_id="O6" value="0.02" spread="0.0728"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.051" spread="0.0907"/>
                    <measurement group_id="O2" value="-0.013" spread="0.0807"/>
                    <measurement group_id="O3" value="0.008" spread="0.1239"/>
                    <measurement group_id="O4" value="0.012" spread="0.0914"/>
                    <measurement group_id="O5" value="0.015" spread="0.0635"/>
                    <measurement group_id="O6" value="0.018" spread="0.0477"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Neutrophils From Baseline</title>
        <description>Change from baseline was calculated as the value at each week minus the value at the baseline.</description>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Neutrophils From Baseline</title>
          <description>Change from baseline was calculated as the value at each week minus the value at the baseline.</description>
          <units>10^9 Neutrophils /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.241" spread="1.1183"/>
                    <measurement group_id="O2" value="-0.105" spread="1.3346"/>
                    <measurement group_id="O3" value="-0.296" spread="0.5781"/>
                    <measurement group_id="O4" value="-0.391" spread="0.7397"/>
                    <measurement group_id="O5" value="-0.147" spread="0.3939"/>
                    <measurement group_id="O6" value="-0.092" spread="0.5560"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.115" spread="1.1387"/>
                    <measurement group_id="O2" value="-0.254" spread="1.0089"/>
                    <measurement group_id="O3" value="-0.313" spread="0.4109"/>
                    <measurement group_id="O4" value="-0.014" spread="0.8032"/>
                    <measurement group_id="O5" value="-0.015" spread="0.5966"/>
                    <measurement group_id="O6" value="-0.044" spread="0.4523"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.273" spread="1.3001"/>
                    <measurement group_id="O2" value="-0.417" spread="1.0814"/>
                    <measurement group_id="O3" value="-0.273" spread="0.4670"/>
                    <measurement group_id="O4" value="-0.208" spread="1.0731"/>
                    <measurement group_id="O5" value="0.116" spread="0.8245"/>
                    <measurement group_id="O6" value="0.011" spread="1.0820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.131" spread="0.8082"/>
                    <measurement group_id="O2" value="0.008" spread="1.1261"/>
                    <measurement group_id="O3" value="0.097" spread="0.9320"/>
                    <measurement group_id="O4" value="0.054" spread="0.7545"/>
                    <measurement group_id="O5" value="-0.025" spread="0.4139"/>
                    <measurement group_id="O6" value="-0.148" spread="0.5358"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.159" spread="0.8592"/>
                    <measurement group_id="O2" value="0.458" spread="1.8931"/>
                    <measurement group_id="O3" value="0.153" spread="1.0128"/>
                    <measurement group_id="O4" value="0.027" spread="0.9118"/>
                    <measurement group_id="O5" value="0.165" spread="0.6483"/>
                    <measurement group_id="O6" value="-0.180" spread="0.6024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.376" spread="1.1492"/>
                    <measurement group_id="O2" value="-0.141" spread="0.8632"/>
                    <measurement group_id="O3" value="-0.151" spread="0.6475"/>
                    <measurement group_id="O4" value="-0.378" spread="0.9802"/>
                    <measurement group_id="O5" value="0.073" spread="0.6629"/>
                    <measurement group_id="O6" value="0.147" spread="0.7146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Monocytes From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Monocytes From Baseline</title>
          <units>10^9 Monocytes /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0040" spread="0.0733"/>
                    <measurement group_id="O2" value="-0.0227" spread="0.11218"/>
                    <measurement group_id="O3" value="-0.0353" spread="0.0689"/>
                    <measurement group_id="O4" value="-0.0525" spread="0.0668"/>
                    <measurement group_id="O5" value="0.0100" spread="0.0860"/>
                    <measurement group_id="O6" value="-0.0307" spread="0.0694"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0733" spread="0.1011"/>
                    <measurement group_id="O2" value="0.0427" spread="0.1353"/>
                    <measurement group_id="O3" value="0.0227" spread="0.1109"/>
                    <measurement group_id="O4" value="0.0144" spread="0.0999"/>
                    <measurement group_id="O5" value="0.0520" spread="0.0844"/>
                    <measurement group_id="O6" value="0.0280" spread="0.0820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0220" spread="0.0668"/>
                    <measurement group_id="O2" value="-0.0327" spread="0.1142"/>
                    <measurement group_id="O3" value="-0.0287" spread="0.0666"/>
                    <measurement group_id="O4" value="-0.0556" spread="0.0909"/>
                    <measurement group_id="O5" value="0.0400" spread="0.1110"/>
                    <measurement group_id="O6" value="-0.0193" spread="0.0656"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0073" spread="0.0612"/>
                    <measurement group_id="O2" value="0.0113" spread="0.1336"/>
                    <measurement group_id="O3" value="-0.0380" spread="0.0927"/>
                    <measurement group_id="O4" value="-0.0431" spread="0.0624"/>
                    <measurement group_id="O5" value="0.0253" spread="0.0801"/>
                    <measurement group_id="O6" value="-0.0227" spread="0.0849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0004" spread="0.0797"/>
                    <measurement group_id="O2" value="0.0007" spread="0.1331"/>
                    <measurement group_id="O3" value="-0.0240" spread="0.0662"/>
                    <measurement group_id="O4" value="-0.0475" spread="0.0772"/>
                    <measurement group_id="O5" value="0.0453" spread="0.0856"/>
                    <measurement group_id="O6" value="-0.0387" spread="0.0605"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0427" spread="0.0707"/>
                    <measurement group_id="O2" value="-0.0107" spread="0.1163"/>
                    <measurement group_id="O3" value="-0.0233" spread="0.1271"/>
                    <measurement group_id="O4" value="-0.0227" spread="0.0960"/>
                    <measurement group_id="O5" value="0.0493" spread="0.1127"/>
                    <measurement group_id="O6" value="-0.0021" spread="0.0567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Lymphocytes From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lymphocytes From Baseline</title>
          <units>10^9 Lymphocytes /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.209" spread="0.5808"/>
                    <measurement group_id="O2" value="-0.060" spread="0.4455"/>
                    <measurement group_id="O3" value="0.077" spread="0.2050"/>
                    <measurement group_id="O4" value="0.179" spread="0.2565"/>
                    <measurement group_id="O5" value="0.115" spread="0.2064"/>
                    <measurement group_id="O6" value="0.179" spread="0.2516"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.247" spread="0.3868"/>
                    <measurement group_id="O2" value="0.257" spread="0.3913"/>
                    <measurement group_id="O3" value="0.169" spread="0.4038"/>
                    <measurement group_id="O4" value="0.109" spread="0.2490"/>
                    <measurement group_id="O5" value="0.249" spread="0.2813"/>
                    <measurement group_id="O6" value="0.184" spread="0.3094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.077" spread="0.4069"/>
                    <measurement group_id="O2" value="-0.023" spread="0.3568"/>
                    <measurement group_id="O3" value="0.013" spread="0.2528"/>
                    <measurement group_id="O4" value="0.010" spread="0.3045"/>
                    <measurement group_id="O5" value="0.03" spread="0.2146"/>
                    <measurement group_id="O6" value="0.103" spread="0.1823"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.012" spread="0.3490"/>
                    <measurement group_id="O2" value="0.063" spread="0.3991"/>
                    <measurement group_id="O3" value="-0.058" spread="0.2627"/>
                    <measurement group_id="O4" value="-0.039" spread="0.2856"/>
                    <measurement group_id="O5" value="0.077" spread="0.2252"/>
                    <measurement group_id="O6" value="0.062" spread="0.2502"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.115" spread="0.4083"/>
                    <measurement group_id="O2" value="-0.045" spread="0.3655"/>
                    <measurement group_id="O3" value="0.015" spread="0.2884"/>
                    <measurement group_id="O4" value="-0.046" spread="0.3200"/>
                    <measurement group_id="O5" value="0.135" spread="0.2941"/>
                    <measurement group_id="O6" value="0.031" spread="0.2214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.219" spread="0.3293"/>
                    <measurement group_id="O2" value="0.027" spread="0.5038"/>
                    <measurement group_id="O3" value="-0.097" spread="0.2514"/>
                    <measurement group_id="O4" value="0.072" spread="0.2427"/>
                    <measurement group_id="O5" value="0.064" spread="0.2607"/>
                    <measurement group_id="O6" value="0.049" spread="0.3324"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Erythrocytes From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Erythrocytes From Baseline</title>
          <units>10^12 Erythrocytes /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.091" spread="0.1603"/>
                    <measurement group_id="O2" value="-0.067" spread="0.2342"/>
                    <measurement group_id="O3" value="-0.037" spread="0.1574"/>
                    <measurement group_id="O4" value="-0.0158" spread="0.2014"/>
                    <measurement group_id="O5" value="-0.066" spread="0.2763"/>
                    <measurement group_id="O6" value="-0.074" spread="0.1644"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.001" spread="0.01757"/>
                    <measurement group_id="O2" value="-0.093" spread="0.220"/>
                    <measurement group_id="O3" value="-0.037" spread="0.2251"/>
                    <measurement group_id="O4" value="-0.084" spread="0.1660"/>
                    <measurement group_id="O5" value="-0.073" spread="0.2447"/>
                    <measurement group_id="O6" value="-0.149" spread="0.0896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.065" spread="0.2011"/>
                    <measurement group_id="O2" value="-0.059" spread="0.2081"/>
                    <measurement group_id="O3" value="-0.039" spread="0.2599"/>
                    <measurement group_id="O4" value="-0.059" spread="0.2024"/>
                    <measurement group_id="O5" value="-0.119" spread="0.2456"/>
                    <measurement group_id="O6" value="-0.079" spread="0.1122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.026" spread="0.2133"/>
                    <measurement group_id="O2" value="0.002" spread="0.2320"/>
                    <measurement group_id="O3" value="0.047" spread="0.3186"/>
                    <measurement group_id="O4" value="-0.024" spread="0.2767"/>
                    <measurement group_id="O5" value="-0.061" spread="0.3035"/>
                    <measurement group_id="O6" value="-0.034" spread="0.1874"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.054" spread="0.1722"/>
                    <measurement group_id="O2" value="-0.036" spread="0.3260"/>
                    <measurement group_id="O3" value="0.027" spread="0.3375"/>
                    <measurement group_id="O4" value="-0.013" spread="0.2587"/>
                    <measurement group_id="O5" value="-0.045" spread="0.2680"/>
                    <measurement group_id="O6" value="-0.070" spread="0.1488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.007" spread="0.2073"/>
                    <measurement group_id="O2" value="-0.046" spread="0.2601"/>
                    <measurement group_id="O3" value="0.001" spread="0.2936"/>
                    <measurement group_id="O4" value="0.018" spread="0.2453"/>
                    <measurement group_id="O5" value="-0.058" spread="0.2505"/>
                    <measurement group_id="O6" value="-0.062" spread="0.1691"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hematocrit From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hematocrit From Baseline</title>
          <units>percentage of Total</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.16" spread="1.446"/>
                    <measurement group_id="O2" value="-0.50" spread="2.429"/>
                    <measurement group_id="O3" value="-0.35" spread="1.280"/>
                    <measurement group_id="O4" value="-1.81" spread="2.05"/>
                    <measurement group_id="O5" value="-1.38" spread="2.155"/>
                    <measurement group_id="O6" value="-0.59" spread="1.499"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="1.552"/>
                    <measurement group_id="O2" value="-0.49" spread="2.086"/>
                    <measurement group_id="O3" value="-0.33" spread="1.991"/>
                    <measurement group_id="O4" value="-0.52" spread="2.004"/>
                    <measurement group_id="O5" value="-0.80" spread="2.267"/>
                    <measurement group_id="O6" value="-1.47" spread="0.647"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="1.492"/>
                    <measurement group_id="O2" value="-0.41" spread="2.004"/>
                    <measurement group_id="O3" value="0.15" spread="2.091"/>
                    <measurement group_id="O4" value="-0.41" spread="2.339"/>
                    <measurement group_id="O5" value="-1.26" spread="2.160"/>
                    <measurement group_id="O6" value="-0.78" spread="0.986"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="1.950"/>
                    <measurement group_id="O2" value=".047" spread="2.132"/>
                    <measurement group_id="O3" value="0.85" spread="2.857"/>
                    <measurement group_id="O4" value="-0.04" spread="2.790"/>
                    <measurement group_id="O5" value="-0.91" spread="2.775"/>
                    <measurement group_id="O6" value="0.05" spread="2.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="1.594"/>
                    <measurement group_id="O2" value="-0.32" spread="3.175"/>
                    <measurement group_id="O3" value="0.61" spread="2.312"/>
                    <measurement group_id="O4" value="-0.13" spread="2.819"/>
                    <measurement group_id="O5" value="-0.49" spread="2.511"/>
                    <measurement group_id="O6" value="-0.59" spread="1.470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="1.758"/>
                    <measurement group_id="O2" value="-0.29" spread="2.534"/>
                    <measurement group_id="O3" value="0.62" spread="2.020"/>
                    <measurement group_id="O4" value="0.32" spread="2.511"/>
                    <measurement group_id="O5" value="-0.81" spread="2.255"/>
                    <measurement group_id="O6" value="-0.79" spread="1.389"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Platelets From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Platelets From Baseline</title>
          <units>10^9 Platelets /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="19.56"/>
                    <measurement group_id="O2" value="-0.1" spread="24.38"/>
                    <measurement group_id="O3" value="1.5" spread="27.38"/>
                    <measurement group_id="O4" value="-3.2" spread="16.20"/>
                    <measurement group_id="O5" value="-8.1" spread="12.15"/>
                    <measurement group_id="O6" value="2.3" spread="21.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.4" spread="25.92"/>
                    <measurement group_id="O2" value="10.5" spread="33.06"/>
                    <measurement group_id="O3" value="20.3" spread="24.62"/>
                    <measurement group_id="O4" value="4.6" spread="17.77"/>
                    <measurement group_id="O5" value="2.7" spread="16.23"/>
                    <measurement group_id="O6" value="6.5" spread="14.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="22.90"/>
                    <measurement group_id="O2" value="-0.2" spread="22.27"/>
                    <measurement group_id="O3" value="6.1" spread="24.28"/>
                    <measurement group_id="O4" value="-0.1" spread="22.93"/>
                    <measurement group_id="O5" value="-1.8" spread="17.76"/>
                    <measurement group_id="O6" value="6.2" spread="16.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="22.90"/>
                    <measurement group_id="O2" value="8.2" spread="31.41"/>
                    <measurement group_id="O3" value="14.2" spread="23.86"/>
                    <measurement group_id="O4" value="-3.8" spread="24.07"/>
                    <measurement group_id="O5" value="2.0" spread="14.11"/>
                    <measurement group_id="O6" value="9.4" spread="28.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" spread="31.26"/>
                    <measurement group_id="O2" value="6.0" spread="30.25"/>
                    <measurement group_id="O3" value="13.3" spread="27.51"/>
                    <measurement group_id="O4" value="-7.1" spread="21.05"/>
                    <measurement group_id="O5" value="-6.3" spread="16.19"/>
                    <measurement group_id="O6" value="0.1" spread="17.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="30.27"/>
                    <measurement group_id="O2" value="11.3" spread="36.34"/>
                    <measurement group_id="O3" value="5.9" spread="18.30"/>
                    <measurement group_id="O4" value="-2.7" spread="31.25"/>
                    <measurement group_id="O5" value="1.9" spread="19.30"/>
                    <measurement group_id="O6" value="-4.4" spread="24.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin From Baseline</title>
        <time_frame>Weeks 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin From Baseline</title>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="5.21"/>
                    <measurement group_id="O2" value="-2.1" spread="6.31"/>
                    <measurement group_id="O3" value="-2.3" spread="4.89"/>
                    <measurement group_id="O4" value="-4.5" spread="5.70"/>
                    <measurement group_id="O5" value="-1.7" spread="7.07"/>
                    <measurement group_id="O6" value="-2.2" spread="4.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="5.54"/>
                    <measurement group_id="O2" value="-2.6" spread="6.33"/>
                    <measurement group_id="O3" value="-2.8" spread="6.14"/>
                    <measurement group_id="O4" value="-3.3" spread="5.51"/>
                    <measurement group_id="O5" value="-2.1" spread="7.45"/>
                    <measurement group_id="O6" value="-3.0" spread="3.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="5.86"/>
                    <measurement group_id="O2" value="-4.8" spread="6.05"/>
                    <measurement group_id="O3" value="-5.8" spread="6.66"/>
                    <measurement group_id="O4" value="-1.6" spread="6.55"/>
                    <measurement group_id="O5" value="-1.9" spread="7.52"/>
                    <measurement group_id="O6" value="1.5" spread="5.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="6.15"/>
                    <measurement group_id="O2" value="-2.9" spread="6.61"/>
                    <measurement group_id="O3" value="-0.9" spread="8.20"/>
                    <measurement group_id="O4" value="0.3" spread="7.84"/>
                    <measurement group_id="O5" value="-1.6" spread="9.45"/>
                    <measurement group_id="O6" value="2.4" spread="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="4.93"/>
                    <measurement group_id="O2" value="-2.6" spread="8.94"/>
                    <measurement group_id="O3" value="0.1" spread="8.71"/>
                    <measurement group_id="O4" value="1.8" spread="8.07"/>
                    <measurement group_id="O5" value="0.6" spread="7.89"/>
                    <measurement group_id="O6" value="0.3" spread="5.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="6.13"/>
                    <measurement group_id="O2" value="-3.1" spread="7.55"/>
                    <measurement group_id="O3" value="0.1" spread="8.09"/>
                    <measurement group_id="O4" value="2.8" spread="6.97"/>
                    <measurement group_id="O5" value="-0.2" spread="7.88"/>
                    <measurement group_id="O6" value="-0.1" spread="5.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Sodium From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sodium From Baseline</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.33"/>
                    <measurement group_id="O2" value="0.6" spread="2.06"/>
                    <measurement group_id="O3" value="0.3" spread="2.29"/>
                    <measurement group_id="O4" value="0.3" spread="1.65"/>
                    <measurement group_id="O5" value="0.6" spread="1.92"/>
                    <measurement group_id="O6" value="1.8" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.72"/>
                    <measurement group_id="O2" value="0.4" spread="2.32"/>
                    <measurement group_id="O3" value="0.3" spread="1.79"/>
                    <measurement group_id="O4" value="0.3" spread="221"/>
                    <measurement group_id="O5" value="-0.5" spread="1.85"/>
                    <measurement group_id="O6" value="1.5" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="1.36"/>
                    <measurement group_id="O2" value="-1.6" spread="1.96"/>
                    <measurement group_id="O3" value="0.1" spread="1.39"/>
                    <measurement group_id="O4" value="-1.1" spread="1.18"/>
                    <measurement group_id="O5" value="0.6" spread="1.92"/>
                    <measurement group_id="O6" value="0.8" spread="2.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="1.56"/>
                    <measurement group_id="O2" value="-0.5" spread="1.81"/>
                    <measurement group_id="O3" value="-0.1" spread="2.03"/>
                    <measurement group_id="O4" value="-0.7" spread="182"/>
                    <measurement group_id="O5" value="0.5" spread="2.07"/>
                    <measurement group_id="O6" value="0.3" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="1.37"/>
                    <measurement group_id="O2" value="-0.9" spread="1.25"/>
                    <measurement group_id="O3" value="1.1" spread="2.31"/>
                    <measurement group_id="O4" value="-0.8" spread="1.84"/>
                    <measurement group_id="O5" value="-0.2" spread="2.11"/>
                    <measurement group_id="O6" value="1.8" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="1.86"/>
                    <measurement group_id="O2" value="-0.3" spread="2.19"/>
                    <measurement group_id="O3" value="1.8" spread="2.01"/>
                    <measurement group_id="O4" value="0.1" spread="1.85"/>
                    <measurement group_id="O5" value="0.9" spread="1.85"/>
                    <measurement group_id="O6" value="2.1" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Potassium From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Potassium From Baseline</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.125" spread="0.3070"/>
                    <measurement group_id="O2" value="-0.007" spread="0.3696"/>
                    <measurement group_id="O3" value="0.189" spread="0.4025"/>
                    <measurement group_id="O4" value="0.036" spread="0.3269"/>
                    <measurement group_id="O5" value="0.239" spread="0.5699"/>
                    <measurement group_id="O6" value="-0.158" spread="0.3481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.057" spread="0.2369"/>
                    <measurement group_id="O2" value="-0.037" spread="0.2778"/>
                    <measurement group_id="O3" value="0.064" spread="0.2900"/>
                    <measurement group_id="O4" value="-0.049" spread="0.4433"/>
                    <measurement group_id="O5" value="-0.137" spread="0.4979"/>
                    <measurement group_id="O6" value="-0.089" spread="0.3626"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.036" spread="0.3004"/>
                    <measurement group_id="O2" value="-0.195" spread="0.2952"/>
                    <measurement group_id="O3" value="0.113" spread="0.34446"/>
                    <measurement group_id="O4" value="0.023" spread="0.4688"/>
                    <measurement group_id="O5" value="-0.023" spread="0.4196"/>
                    <measurement group_id="O6" value="-0.227" spread="0.3090"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.028" spread="0.3874"/>
                    <measurement group_id="O2" value="0.045" spread="0.3680"/>
                    <measurement group_id="O3" value="0.241" spread="0.3395"/>
                    <measurement group_id="O4" value="-0.008" spread="0.4328"/>
                    <measurement group_id="O5" value="0.271" spread="0.3383"/>
                    <measurement group_id="O6" value="-0.209" spread="0.3582"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.040" spread="0.4153"/>
                    <measurement group_id="O2" value="-0.205" spread="0.4556"/>
                    <measurement group_id="O3" value="0.217" spread="0.2773"/>
                    <measurement group_id="O4" value="0.072" spread="0.3896"/>
                    <measurement group_id="O5" value="0.089" spread="0.2322"/>
                    <measurement group_id="O6" value="-0.110" spread="0.2961"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.061" spread="0.2474"/>
                    <measurement group_id="O2" value="0.161" spread="0.2367"/>
                    <measurement group_id="O3" value="0.324" spread="0.2924"/>
                    <measurement group_id="O4" value="0.023" spread="0.2988"/>
                    <measurement group_id="O5" value="0.253" spread="0.410"/>
                    <measurement group_id="O6" value="-0.190" spread="0.3313"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Alkaline Phosphatase From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Alkaline Phosphatase From Baseline</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="7.52"/>
                    <measurement group_id="O2" value="0.7" spread="4.92"/>
                    <measurement group_id="O3" value="-3.7" spread="6.52"/>
                    <measurement group_id="O4" value="-4.9" spread="4.89"/>
                    <measurement group_id="O5" value="-0.7" spread="6.76"/>
                    <measurement group_id="O6" value="0.9" spread="6.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="7.06"/>
                    <measurement group_id="O2" value="2.0" spread="6.63"/>
                    <measurement group_id="O3" value="-4.7" spread="6.43"/>
                    <measurement group_id="O4" value="-1.8" spread="5.39"/>
                    <measurement group_id="O5" value="-4.3" spread="5.61"/>
                    <measurement group_id="O6" value="0.3" spread="7.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="9.62"/>
                    <measurement group_id="O2" value="-0.4" spread="5.74"/>
                    <measurement group_id="O3" value="3.6" spread="7.52"/>
                    <measurement group_id="O4" value="-2.4" spread="6.31"/>
                    <measurement group_id="O5" value="-2.7" spread="6.60"/>
                    <measurement group_id="O6" value="3.2" spread="4.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="6.31"/>
                    <measurement group_id="O2" value="2.5" spread="5.36"/>
                    <measurement group_id="O3" value="1.1" spread="6.35"/>
                    <measurement group_id="O4" value="-2.4" spread="5.94"/>
                    <measurement group_id="O5" value="3.5" spread="6.24"/>
                    <measurement group_id="O6" value="4.1" spread="5.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="11.92"/>
                    <measurement group_id="O2" value="3.2" spread="5.91"/>
                    <measurement group_id="O3" value="3.9" spread="7.81"/>
                    <measurement group_id="O4" value="-1.1" spread="5.48"/>
                    <measurement group_id="O5" value="-2.1" spread="10.02"/>
                    <measurement group_id="O6" value="0.1" spread="6.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="8.17"/>
                    <measurement group_id="O2" value="5.3" spread="9.49"/>
                    <measurement group_id="O3" value="3.3" spread="9.50"/>
                    <measurement group_id="O4" value="-1.7" spread="7.01"/>
                    <measurement group_id="O5" value="2.1" spread="11.48"/>
                    <measurement group_id="O6" value="2.3" spread="8.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Alanine Aminotransferase From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Alanine Aminotransferase From Baseline</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="6.69"/>
                    <measurement group_id="O2" value="2.3" spread="6.33"/>
                    <measurement group_id="O3" value="-0.2" spread="2.91"/>
                    <measurement group_id="O4" value="-1.8" spread="2.44"/>
                    <measurement group_id="O5" value="4.3" spread="20.30"/>
                    <measurement group_id="O6" value="0.2" spread="3.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="16.39"/>
                    <measurement group_id="O2" value="2.0" spread="5.13"/>
                    <measurement group_id="O3" value="2.5" spread="5.25"/>
                    <measurement group_id="O4" value="-1.1" spread="3.26"/>
                    <measurement group_id="O5" value="2.6" spread="3.98"/>
                    <measurement group_id="O6" value="0.9" spread="3.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="10.91"/>
                    <measurement group_id="O2" value="2.9" spread="3.81"/>
                    <measurement group_id="O3" value="0.9" spread="6.65"/>
                    <measurement group_id="O4" value="0.9" spread="3.96"/>
                    <measurement group_id="O5" value="0.1" spread="3.84"/>
                    <measurement group_id="O6" value="0.7" spread="4.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="12.13"/>
                    <measurement group_id="O2" value="4.1" spread="6.08"/>
                    <measurement group_id="O3" value="0.1" spread="5.46"/>
                    <measurement group_id="O4" value="-1.4" spread="5.26"/>
                    <measurement group_id="O5" value="0.8" spread="7.02"/>
                    <measurement group_id="O6" value="-0.1" spread="2.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="12.59"/>
                    <measurement group_id="O2" value="4.9" spread="6.33"/>
                    <measurement group_id="O3" value="3.9" spread="9.84"/>
                    <measurement group_id="O4" value="-0.5" spread="8.22"/>
                    <measurement group_id="O5" value="0.4" spread="3.76"/>
                    <measurement group_id="O6" value="-1.1" spread="3.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="11.81"/>
                    <measurement group_id="O2" value="1.2" spread="4.20"/>
                    <measurement group_id="O3" value="0.3" spread="10.26"/>
                    <measurement group_id="O4" value="10." spread="3.38"/>
                    <measurement group_id="O5" value="-0.3" spread="6.31"/>
                    <measurement group_id="O6" value="-0.9" spread="3.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Aspartate Aminotransferase From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Aspartate Aminotransferase From Baseline</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.60" spread="4.982"/>
                    <measurement group_id="O2" value="0.40" spread="4.768"/>
                    <measurement group_id="O3" value="-0.40" spread="2.898"/>
                    <measurement group_id="O4" value="-1.38" spread="4.530"/>
                    <measurement group_id="O5" value="3.93" spread="11.738"/>
                    <measurement group_id="O6" value="-1.33" spread="2.380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.07" spread="32.288"/>
                    <measurement group_id="O2" value="0.29" spread="3.106"/>
                    <measurement group_id="O3" value="2.27" spread="3.262"/>
                    <measurement group_id="O4" value="-2.44" spread="5.151"/>
                    <measurement group_id="O5" value="0.07" spread="3.150"/>
                    <measurement group_id="O6" value="-0.80" spread="3.649"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="4.518"/>
                    <measurement group_id="O2" value="2.53" spread="3.067"/>
                    <measurement group_id="O3" value="0.87" spread="4.015"/>
                    <measurement group_id="O4" value="0.69" spread="4.191"/>
                    <measurement group_id="O5" value="1.47" spread="3.720"/>
                    <measurement group_id="O6" value="-0.93" spread="3.240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="4.480"/>
                    <measurement group_id="O2" value="1.20" spread="5.735"/>
                    <measurement group_id="O3" value="1.13" spread="3.623"/>
                    <measurement group_id="O4" value="-2.50" spread="4.487"/>
                    <measurement group_id="O5" value="1.13" spread="4.340"/>
                    <measurement group_id="O6" value="-0.93" spread="3.411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="6.147"/>
                    <measurement group_id="O2" value="2.47" spread="4.533"/>
                    <measurement group_id="O3" value="2.20" spread="4.109"/>
                    <measurement group_id="O4" value=".194" spread="4.106"/>
                    <measurement group_id="O5" value="-0.20" spread="3.986"/>
                    <measurement group_id="O6" value="0.13" spread="3.739"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="6.091"/>
                    <measurement group_id="O2" value="0.87" spread="2.774"/>
                    <measurement group_id="O3" value="0.07" spread="5.391"/>
                    <measurement group_id="O4" value="-1.53" spread="4.357"/>
                    <measurement group_id="O5" value="4.27" spread="18.763"/>
                    <measurement group_id="O6" value="-0.29" spread="3.384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Direct Bilirubin Form Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Direct Bilirubin Form Baseline</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1026" spread="0.9712"/>
                    <measurement group_id="O2" value="-0.3420" spread="0.9950"/>
                    <measurement group_id="O3" value="-0.2622" spread="1.5375"/>
                    <measurement group_id="O4" value="-0.0214" spread="1.0992"/>
                    <measurement group_id="O5" value="0.2280" spread="0.8878"/>
                    <measurement group_id="O6" value="0.2280" spread="0.8419"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4140" spread="0.8857"/>
                    <measurement group_id="O2" value="4.5942" spread="17.8620"/>
                    <measurement group_id="O3" value="-0.1482" spread="1.1559"/>
                    <measurement group_id="O4" value="-0.1603" spread="0.6767"/>
                    <measurement group_id="O5" value="-0.0684" spread="0.05040"/>
                    <measurement group_id="O6" value="-0.0570" spread="0.7129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1140" spread="0.7907"/>
                    <measurement group_id="O2" value="0.3762" spread="0.9053"/>
                    <measurement group_id="O3" value="-0.1710" spread="1.6503"/>
                    <measurement group_id="O4" value="-0.0107" spread="0.7835"/>
                    <measurement group_id="O5" value="0.0570" spread="0.7331"/>
                    <measurement group_id="O6" value="-0.1254" spread="0.8802"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6498" spread="0.8155"/>
                    <measurement group_id="O2" value="0.2394" spread="0.9362"/>
                    <measurement group_id="O3" value="-0.1026" spread="1.8449"/>
                    <measurement group_id="O4" value="0.0962" spread="1.1945"/>
                    <measurement group_id="O5" value="0.0570" spread="0.8783"/>
                    <measurement group_id="O6" value="0.1140" spread="0.6452"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4789" spread="1.4059"/>
                    <measurement group_id="O2" value="0.1938" spread="0.9209"/>
                    <measurement group_id="O3" value="-0.3534" spread="1.3718"/>
                    <measurement group_id="O4" value="-0.1603" spread="0.8365"/>
                    <measurement group_id="O5" value="-0.6270" spread="0.7720"/>
                    <measurement group_id="O6" value="-0.0228" spread="0.8547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0114" spread="0.8610"/>
                    <measurement group_id="O2" value="0.0689" spread="0.9883"/>
                    <measurement group_id="O3" value="-0.1482" spread="2.1081"/>
                    <measurement group_id="O4" value="0.1254" spread="0.9531"/>
                    <measurement group_id="O5" value="-0.0342" spread="1.2181"/>
                    <measurement group_id="O6" value="0.1710" spread="0.6938"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Bilirubin From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bilirubin From Baseline</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3534" spread="3.7254"/>
                    <measurement group_id="O2" value="-1.1970" spread="3.7725"/>
                    <measurement group_id="O3" value="0.1048" spread="5.4294"/>
                    <measurement group_id="O4" value="0.0641" spread="4.2155"/>
                    <measurement group_id="O5" value="-0.0228" spread="3.5705"/>
                    <measurement group_id="O6" value="0.5586" spread="2.8697"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1286" spread="3.4315"/>
                    <measurement group_id="O2" value="-0.1938" spread="3.5435"/>
                    <measurement group_id="O3" value="-0.1824" spread="4.4841"/>
                    <measurement group_id="O4" value="-0.4275" spread="2.54871"/>
                    <measurement group_id="O5" value="-0.7980" spread="1.7181"/>
                    <measurement group_id="O6" value="-0.7069" spread="2.5436"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7068" spread="3.0527"/>
                    <measurement group_id="O2" value="1.0146" spread="3.526"/>
                    <measurement group_id="O3" value="-0.2736" spread="6.4174"/>
                    <measurement group_id="O4" value="0.1176" spread="2.9557"/>
                    <measurement group_id="O5" value="-0.0456" spread="2.7064"/>
                    <measurement group_id="O6" value="-0.6954" spread="2.9706"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1546" spread="3.7037"/>
                    <measurement group_id="O2" value="0.2280" spread="3.2820"/>
                    <measurement group_id="O3" value="0.2052" spread="7.1427"/>
                    <measurement group_id="O4" value="0.0534" spread="3.9465"/>
                    <measurement group_id="O5" value="-0.5244" spread="3.0702"/>
                    <measurement group_id="O6" value="-0.3192" spread="1.9269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9038" spread="6.9092"/>
                    <measurement group_id="O2" value="0.3078" spread="3.7354"/>
                    <measurement group_id="O3" value="-0.6954" spread="5.6701"/>
                    <measurement group_id="O4" value="-1.1222" spread="2.5108"/>
                    <measurement group_id="O5" value="-2.6220" spread="2.8960"/>
                    <measurement group_id="O6" value="-0.3420" spread="3.1431"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7524" spread="2.8223"/>
                    <measurement group_id="O2" value="0.05586" spread="3.9258"/>
                    <measurement group_id="O3" value="23.9286" spread="91.7547"/>
                    <measurement group_id="O4" value="-0.0114" spread="3.4670"/>
                    <measurement group_id="O5" value="-0.3078" spread="4.4235"/>
                    <measurement group_id="O6" value="-0.1954" spread="2.9227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Albumin Form Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Albumin Form Baseline</title>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.45" spread="2.989"/>
                    <measurement group_id="O2" value="-0.65" spread="2.370"/>
                    <measurement group_id="O3" value="-1.70" spread="2.6376"/>
                    <measurement group_id="O4" value="-1.67" spread="2.775"/>
                    <measurement group_id="O5" value="0.03" spread="2.343"/>
                    <measurement group_id="O6" value="-0.64" spread="2.346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="2.334"/>
                    <measurement group_id="O2" value="-0.83" spread="3.253"/>
                    <measurement group_id="O3" value="-1.37" spread="2.943"/>
                    <measurement group_id="O4" value="-1.03" spread="1.1885"/>
                    <measurement group_id="O5" value="-0.73" spread="2.504"/>
                    <measurement group_id="O6" value="-1.61" spread="1.739"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" spread="3.150"/>
                    <measurement group_id="O2" value="-159" spread="2.035"/>
                    <measurement group_id="O3" value="-0.08" spread="2.486"/>
                    <measurement group_id="O4" value="-1.00" spread="2.055"/>
                    <measurement group_id="O5" value="-1.53" spread="2.707"/>
                    <measurement group_id="O6" value="-0.87" spread="2.408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="2.666"/>
                    <measurement group_id="O2" value="-2.07" spread="2.587"/>
                    <measurement group_id="O3" value="0.71" spread="2.619"/>
                    <measurement group_id="O4" value="-1.47" spread="2.587"/>
                    <measurement group_id="O5" value="-2.43" spread="2.880"/>
                    <measurement group_id="O6" value="-0.45" spread="2.770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.86" spread="2.442"/>
                    <measurement group_id="O2" value="-1.68" spread="2.815"/>
                    <measurement group_id="O3" value="-0.25" spread="2.167"/>
                    <measurement group_id="O4" value="-0.64" spread="2.2143"/>
                    <measurement group_id="O5" value="-0.93" spread="1.617"/>
                    <measurement group_id="O6" value="-0.13" spread="1.848"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.62" spread="2.155"/>
                    <measurement group_id="O2" value="-2.56" spread="2.201"/>
                    <measurement group_id="O3" value="-1.59" spread="2.630"/>
                    <measurement group_id="O4" value="-1.21" spread="2.811"/>
                    <measurement group_id="O5" value="-0.07" spread="3.501"/>
                    <measurement group_id="O6" value="1.21" spread="2.598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Creatinine Form Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Creatinine Form Baseline</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6483" spread="5.2878"/>
                    <measurement group_id="O2" value="-2.9467" spread="5.8701"/>
                    <measurement group_id="O3" value="1.4733" spread="3.9908"/>
                    <measurement group_id="O4" value="-4.0333" spread="8.5827"/>
                    <measurement group_id="O5" value="1.2963" spread="9.553"/>
                    <measurement group_id="O6" value="-0.5304" spread="7.3491"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5323" spread="5.3404"/>
                    <measurement group_id="O2" value="-2.1805" spread="4.9992"/>
                    <measurement group_id="O3" value="2.1216" spread="37176"/>
                    <measurement group_id="O4" value="0.3315" spread="7.9125"/>
                    <measurement group_id="O5" value="0.3536" spread="5.9657"/>
                    <measurement group_id="O6" value="-1.3555" spread="6.7561"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3575" spread="4.4284"/>
                    <measurement group_id="O2" value="-4.2432" spread="4.7511"/>
                    <measurement group_id="O3" value="1.6501" spread="5.2284"/>
                    <measurement group_id="O4" value="-2.4310" spread="8.9600"/>
                    <measurement group_id="O5" value="-1.8959" spread="6.6394"/>
                    <measurement group_id="O6" value="-1.7680" spread="5.9017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2116" spread="6.3904"/>
                    <measurement group_id="O2" value="-0.3536" spread="5.6088"/>
                    <measurement group_id="O3" value="2.4163" spread="3.0889"/>
                    <measurement group_id="O4" value="-3.228" spread="8.9278"/>
                    <measurement group_id="O5" value="-1.5912" spread="4.6442"/>
                    <measurement group_id="O6" value="-2.1216" spread="5.4779"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5893" spread="6.8610"/>
                    <measurement group_id="O2" value="-2.8288" spread="5.5929"/>
                    <measurement group_id="O3" value="1.1787" spread="3.2680"/>
                    <measurement group_id="O4" value="-3.0940" spread="10.4097"/>
                    <measurement group_id="O5" value="-4.4789" spread="6.7279"/>
                    <measurement group_id="O6" value="-3.2413" spread="5.6175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.9504" spread="5.6088"/>
                    <measurement group_id="O2" value="-2.0037" spread="4.6112"/>
                    <measurement group_id="O3" value="-0.11799" spread="5.382"/>
                    <measurement group_id="O4" value="-4.2432" spread="9.2244"/>
                    <measurement group_id="O5" value="-3.1824" spread="5.9751"/>
                    <measurement group_id="O6" value="-1.6417" spread="7.1888"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Lactate Dehydrogenase From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lactate Dehydrogenase From Baseline</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.5" spread="12.69"/>
                    <measurement group_id="O2" value="0.5" spread="20.00"/>
                    <measurement group_id="O3" value="6.5" spread="15.62"/>
                    <measurement group_id="O4" value="-10.8" spread="17.09"/>
                    <measurement group_id="O5" value="-2.6" spread="19.82"/>
                    <measurement group_id="O6" value="0.9" spread="14.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="35.25"/>
                    <measurement group_id="O2" value="1.4" spread="21.89"/>
                    <measurement group_id="O3" value="7.3" spread="17.99"/>
                    <measurement group_id="O4" value="-7.0" spread="20.64"/>
                    <measurement group_id="O5" value="-10.9" spread="13.17"/>
                    <measurement group_id="O6" value="-5.7" spread="16.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="16.46"/>
                    <measurement group_id="O2" value="-1.7" spread="18.67"/>
                    <measurement group_id="O3" value="5.1" spread="15.34"/>
                    <measurement group_id="O4" value="2.1" spread="12.37"/>
                    <measurement group_id="O5" value="1.3" spread="17.54"/>
                    <measurement group_id="O6" value="-3.9" spread="19.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="10.31"/>
                    <measurement group_id="O2" value="-2.4" spread="16.82"/>
                    <measurement group_id="O3" value="14.2" spread="24.40"/>
                    <measurement group_id="O4" value="-11.2" spread="17.86"/>
                    <measurement group_id="O5" value="3.7" spread="37.19"/>
                    <measurement group_id="O6" value="-4.2" spread="17.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.1" spread="13.48"/>
                    <measurement group_id="O2" value="-3.8" spread="20.23"/>
                    <measurement group_id="O3" value="1.3" spread="16.86"/>
                    <measurement group_id="O4" value="-10.1" spread="17.55"/>
                    <measurement group_id="O5" value="-8.9" spread="15.95"/>
                    <measurement group_id="O6" value="-3.4" spread="23.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.4" spread="18.26"/>
                    <measurement group_id="O2" value="-3.3" spread="20.58"/>
                    <measurement group_id="O3" value="-2.1" spread="12.06"/>
                    <measurement group_id="O4" value="-10.0" spread="19.42"/>
                    <measurement group_id="O5" value="-3.1" spread="22.96"/>
                    <measurement group_id="O6" value="2.4" spread="25.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Urea Nitrogen From Baseline</title>
        <time_frame>week 1,2,4,8,12, and 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Urea Nitrogen From Baseline</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0571" spread="1.9802"/>
                    <measurement group_id="O2" value="0.0524" spread="1.5732"/>
                    <measurement group_id="O3" value="-0.5712" spread="2.7988"/>
                    <measurement group_id="O4" value="0.1428" spread="2.0927"/>
                    <measurement group_id="O5" value="-0.4712" spread="1.5268"/>
                    <measurement group_id="O6" value="-0.3237" spread="2.4570"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2951" spread="1.9132"/>
                    <measurement group_id="O2" value="0.5284" spread="2.2289"/>
                    <measurement group_id="O3" value="-0.9377" spread="3.3246"/>
                    <measurement group_id="O4" value="-0.2365" spread="2.2977"/>
                    <measurement group_id="O5" value="0.7854" spread="1.2804"/>
                    <measurement group_id="O6" value="-0.6378" spread="2.4125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1571" spread="2.2931"/>
                    <measurement group_id="O2" value="-0.1856" spread="1.6149"/>
                    <measurement group_id="O3" value="-0.1428" spread="2.3668"/>
                    <measurement group_id="O4" value="-0.3570" spread="2.0358"/>
                    <measurement group_id="O5" value="-0.6474" spread="1.8290"/>
                    <measurement group_id="O6" value="-0.5807" spread="2.3925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4522" spread="2.0612"/>
                    <measurement group_id="O2" value="-0.0286" spread="1.5584"/>
                    <measurement group_id="O3" value="-0.0952" spread="2.322"/>
                    <measurement group_id="O4" value="-0.0759" spread="2.3484"/>
                    <measurement group_id="O5" value="-1.0900" spread="2.3572"/>
                    <measurement group_id="O6" value="0.3237" spread="2.1001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0143" spread="1.8835"/>
                    <measurement group_id="O2" value="0.1000" spread="2.1727"/>
                    <measurement group_id="O3" value="-0.6045" spread="2.6703"/>
                    <measurement group_id="O4" value="0.3525" spread="2.3561"/>
                    <measurement group_id="O5" value="-0.4667" spread="2.1063"/>
                    <measurement group_id="O6" value="-0.6426" spread="1.9342"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0619" spread="1.7148"/>
                    <measurement group_id="O2" value="0.2667" spread="2.8833"/>
                    <measurement group_id="O3" value="-0.5331" spread="2.3939"/>
                    <measurement group_id="O4" value="0.5379" spread="2.3910"/>
                    <measurement group_id="O5" value="-0.2999" spread="1.5902"/>
                    <measurement group_id="O6" value="-0.1989" spread="2.9145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Positive, Negative or Indeterminate Seroconversion for Anti-s Antibody</title>
        <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
Immunogenicity Result: Seroconversion for Anti-S Antibody&#xD;
Interpretation: n. of subjects positive, negative or indeterminate at week 1, 2, 4, 8, 12, and 24 after vaccination.</description>
        <time_frame>week 1, 2, 4, 8, 12, and 24</time_frame>
        <population>One subject in arm-1 low dose (adult cohort) had an asymptomatic infection around the time of vaccination. This was discovered post hoc, and this subject was excluded from all Immunogenicity Analysis Set(IAS).&#xD;
One subject in Arm-4 low dose (elderly cohort) had a suspicious non-specific reactivity to the tests and was excluded from the IAS.&#xD;
Other specification: % = Calculated as nr. of subjects within category divided by nr. of subjects with non-missing observation at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=14&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive, Negative or Indeterminate Seroconversion for Anti-s Antibody</title>
          <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
Immunogenicity Result: Seroconversion for Anti-S Antibody&#xD;
Interpretation: n. of subjects positive, negative or indeterminate at week 1, 2, 4, 8, 12, and 24 after vaccination.</description>
          <population>One subject in arm-1 low dose (adult cohort) had an asymptomatic infection around the time of vaccination. This was discovered post hoc, and this subject was excluded from all Immunogenicity Analysis Set(IAS).&#xD;
One subject in Arm-4 low dose (elderly cohort) had a suspicious non-specific reactivity to the tests and was excluded from the IAS.&#xD;
Other specification: % = Calculated as nr. of subjects within category divided by nr. of subjects with non-missing observation at each time point.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>indeterminate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Positive, Negative Anti-n Antibody</title>
        <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
cellular and humoral immune parameters evaluated: anti-N Antibody Interpretation: n. of subjects positive, negative at week 1, 2, 4, 8, 12 and 24 compared to baseline</description>
        <time_frame>week 1, 2, 4, 8, 12 and 24</time_frame>
        <population>One subject in arm-1 low dose (adult cohort) had an asymptomatic infection around the time of vaccination. This was discovered post hoc, and this subject was excluded from all Immunogenicity Analysis Set(IAS).&#xD;
One subject in Arm-4 low dose (elderly cohort) had a suspicious non-specific reactivity to the tests and was excluded from the IAS.&#xD;
Other specification: % = Calculated as nr. of subjects within category divided by nr. of subjects with non-missing observation at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=14&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15 GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive, Negative Anti-n Antibody</title>
          <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine&#xD;
cellular and humoral immune parameters evaluated: anti-N Antibody Interpretation: n. of subjects positive, negative at week 1, 2, 4, 8, 12 and 24 compared to baseline</description>
          <population>One subject in arm-1 low dose (adult cohort) had an asymptomatic infection around the time of vaccination. This was discovered post hoc, and this subject was excluded from all Immunogenicity Analysis Set(IAS).&#xD;
One subject in Arm-4 low dose (elderly cohort) had a suspicious non-specific reactivity to the tests and was excluded from the IAS.&#xD;
Other specification: % = Calculated as nr. of subjects within category divided by nr. of subjects with non-missing observation at each time point.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Positive, Negative for Micro Neutralization Test</title>
        <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated: Micro Neutralization test&#xD;
Interpretation: n. of positive and negative subjects at week 4 and week 24 by evaluating geometric mean titer change from baseline</description>
        <time_frame>week 4 and week 24</time_frame>
        <population>number of subjects analyzed is calculated based on number of subjects with non missing observation thus numbers of subjects analyzed may vary between the observation period.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=14&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive, Negative for Micro Neutralization Test</title>
          <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated: Micro Neutralization test&#xD;
Interpretation: n. of positive and negative subjects at week 4 and week 24 by evaluating geometric mean titer change from baseline</description>
          <population>number of subjects analyzed is calculated based on number of subjects with non missing observation thus numbers of subjects analyzed may vary between the observation period.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>positive week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Immunogenicity - T-cell Response</title>
        <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated.&#xD;
T-cells were evaluated on frozen and fresh (week2) samples&#xD;
Within-cohort comparisons to assess the difference in immune response according to different doses in the same population Across-the-cohort comparison to assess whether elderlies and adults have a different pattern of immune response after vaccination at different endpoints&#xD;
Unit: spot-forming cells [SFC]/1 × 10^6 peripheral blood mononuclear cell [PBMC]&#xD;
Interpretation: values higher than at baseline are indicative of a persistent spike-specific memory T-cell establishment.</description>
        <time_frame>baseline, week 2, week 4, week 8, week 12, week 24</time_frame>
        <population>number of subjects analyzed is calculated based on number of subjects with non missing observation thus numbers of subjects analyzed may vary between the observation period.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 - Low Dose</title>
            <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=14&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Intermediate Dose</title>
            <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - High Dose</title>
            <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Low Dose</title>
            <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O5">
            <title>Arm 5 - Intermediate Dose</title>
            <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
          <group group_id="O6">
            <title>Arm 6 - High Dose</title>
            <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
          </group>
        </group_list>
        <measure>
          <title>Immunogenicity - T-cell Response</title>
          <description>To assess the cellular and humoral immune response to SARS-CoV2 elicited by the vaccine cellular and humoral immune parameters evaluated.&#xD;
T-cells were evaluated on frozen and fresh (week2) samples&#xD;
Within-cohort comparisons to assess the difference in immune response according to different doses in the same population Across-the-cohort comparison to assess whether elderlies and adults have a different pattern of immune response after vaccination at different endpoints&#xD;
Unit: spot-forming cells [SFC]/1 × 10^6 peripheral blood mononuclear cell [PBMC]&#xD;
Interpretation: values higher than at baseline are indicative of a persistent spike-specific memory T-cell establishment.</description>
          <population>number of subjects analyzed is calculated based on number of subjects with non missing observation thus numbers of subjects analyzed may vary between the observation period.</population>
          <units>SFC/1x10^6 PBMC</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>T-cell response baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54" lower_limit="23.0" upper_limit="88.0"/>
                    <measurement group_id="O2" value="88.0" lower_limit="43.0" upper_limit="138.0"/>
                    <measurement group_id="O3" value="128.0" lower_limit="65.0" upper_limit="213.0"/>
                    <measurement group_id="O4" value="320.0" lower_limit="78.0" upper_limit="760.0"/>
                    <measurement group_id="O5" value="165.0" lower_limit="128.0" upper_limit="565.0"/>
                    <measurement group_id="O6" value="425.0" lower_limit="295.0" upper_limit="1050.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 2 (fresh samples)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1161.0" lower_limit="438.0" upper_limit="2430.0"/>
                    <measurement group_id="O2" value="2857.0" lower_limit="412.0" upper_limit="4702.0"/>
                    <measurement group_id="O3" value="2272.0" lower_limit="1243.0" upper_limit="3568.0"/>
                    <measurement group_id="O4" value="1917.0" lower_limit="1353.0" upper_limit="3613.0"/>
                    <measurement group_id="O5" value="2262.0" lower_limit="1228.0" upper_limit="3942.0"/>
                    <measurement group_id="O6" value="3142.0" lower_limit="1555.0" upper_limit="8265.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 2 (frozen samples)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1214.0" lower_limit="465.0" upper_limit="1475.0"/>
                    <measurement group_id="O2" value="1095.0" lower_limit="328.0" upper_limit="3083.0"/>
                    <measurement group_id="O3" value="905.0" lower_limit="743.0" upper_limit="1465.0"/>
                    <measurement group_id="O4" value="1258.0" lower_limit="975.0" upper_limit="2790.0"/>
                    <measurement group_id="O5" value="1363.0" lower_limit="570.0" upper_limit="2285.0"/>
                    <measurement group_id="O6" value="1618.0" lower_limit="1010.0" upper_limit="5785.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="788.0" lower_limit="425.0" upper_limit="1353.0"/>
                    <measurement group_id="O2" value="1120.0" lower_limit="368.0" upper_limit="2193.0"/>
                    <measurement group_id="O3" value="1330.0" lower_limit="573.0" upper_limit="2285.0"/>
                    <measurement group_id="O4" value="1153.0" lower_limit="745.0" upper_limit="2188.0"/>
                    <measurement group_id="O5" value="1258.0" lower_limit="395.0" upper_limit="2000.0"/>
                    <measurement group_id="O6" value="1645.0" lower_limit="1183.0" upper_limit="4215.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="720.0" lower_limit="355.0" upper_limit="945.0"/>
                    <measurement group_id="O2" value="948.0" lower_limit="329.0" upper_limit="1468.0"/>
                    <measurement group_id="O3" value="1172.0" lower_limit="628.0" upper_limit="1570.0"/>
                    <measurement group_id="O4" value="898.0" lower_limit="403.0" upper_limit="1273.0"/>
                    <measurement group_id="O5" value="888.0" lower_limit="353.0" upper_limit="1920.0"/>
                    <measurement group_id="O6" value="2133.0" lower_limit="945.0" upper_limit="3538.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="570.0" lower_limit="458.0" upper_limit="733.0"/>
                    <measurement group_id="O2" value="655.0" lower_limit="368.0" upper_limit="1073.0"/>
                    <measurement group_id="O3" value="856.0" lower_limit="570.0" upper_limit="1553.0"/>
                    <measurement group_id="O4" value="898.0" lower_limit="435.0" upper_limit="1670.0"/>
                    <measurement group_id="O5" value="835.0" lower_limit="358.0" upper_limit="1278.0"/>
                    <measurement group_id="O6" value="1435.0" lower_limit="760.0" upper_limit="2943.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T-cell response week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="13"/>
                    <count group_id="O6" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="538.0" lower_limit="243.0" upper_limit="693.0"/>
                    <measurement group_id="O2" value="500.0" lower_limit="238.0" upper_limit="918.0"/>
                    <measurement group_id="O3" value="798.0" lower_limit="220.0" upper_limit="968.0"/>
                    <measurement group_id="O4" value="740.5" lower_limit="529.0" upper_limit="936.5"/>
                    <measurement group_id="O5" value="643.0" lower_limit="468.0" upper_limit="823.0"/>
                    <measurement group_id="O6" value="1223.0" lower_limit="823.0" upper_limit="1930.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event occurred during the study period from enrollment to week 24</time_frame>
      <desc>Adverse events summarized by system organ class (SOC) and preferred term (PT), with number and percentage of subjects as well as the total number of occurrences.&#xD;
Adverse event summaries were ordered in terms of decreasing frequency for SOC and PT within SOC in the Total group and then alphabetically for SOC and PT within SOC. Summaries were ordered in terms of decreasing frequency for PT in the Total group in summaries where SOC was not included.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1 - Low Dose</title>
          <description>Arm-1 Healthy adult volunteers aged 18-55y will receive IM single dose of 5e10vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2 - Intermediate Dose</title>
          <description>Arm-2 Healthy adult volunteers aged 18-55y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="E3">
          <title>Arm 3 - High Dose</title>
          <description>Arm-3 Healthy adult volunteers aged 18-55y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="E4">
          <title>Arm 4 - Low Dose</title>
          <description>Arm-4 Healthy elderly volunteers aged 65-85y will receive IM single dose of 5e10vp. N=16&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="E5">
          <title>Arm 5 - Intermediate Dose</title>
          <description>Arm-5 Healthy elderly volunteers aged 65-85y will receive IM single dose of 1e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
        <group group_id="E6">
          <title>Arm 6 - High Dose</title>
          <description>Arm-6 Healthy elderly volunteers aged 65-85y will receive IM single dose of 2e11vp. N=15&#xD;
GRAd-COV2: Single intramuscular administration.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA v. 23.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="16"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Neutropoenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Chalazion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Faeces Soft</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="31" subjects_affected="9" subjects_at_risk="15"/>
                <counts group_id="E2" events="35" subjects_affected="7" subjects_at_risk="15"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E4" events="13" subjects_affected="7" subjects_at_risk="16"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>injection site pain</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="15"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E3" events="15" subjects_affected="11" subjects_at_risk="15"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E5" events="11" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E4" events="7" subjects_affected="4" subjects_at_risk="16"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E6" events="7" subjects_affected="6" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Injection Site Erithema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Injection Site swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Injection Site hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Oral Herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Tooth Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Tooth Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate Aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperkaliemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E4" events="12" subjects_affected="6" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Muscle contracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="11" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E2" events="16" subjects_affected="8" subjects_at_risk="15"/>
                <counts group_id="E3" events="15" subjects_affected="11" subjects_at_risk="15"/>
                <counts group_id="E4" events="10" subjects_affected="7" subjects_at_risk="16"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Premenstrual Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot Flush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of the results will be agreed between ReiThera SRL and Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani. If one of the parties is interested in proceeding with a scientific publication, it must give written and electronic communication to the other party. Any impediments to publication must be communicated electronically within 30 days. If a party deems it inappropriate to publish, it will try to provide written changes to the text that could allow its publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Reithera</organization>
      <phone>06 99775 ext 352</phone>
      <email>roberto.camerini@reithera.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

